Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Ocular Oncology and Pathology

• Publication date

  2016-07-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000447300PMID 27843907PMCID PMC5091129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of HMGA2 protein synthesis could be a tool for the therapy of well differentiated liposarcomas overexpressing HMGA2.

  2018cited by this paper
• Erratum: "Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells" [Biomicrofluidics 9(5), 054110 (2015)].

  2017cited by this paper
• Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.

  2016cited by this paper
• Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML

  2016cited by this paper
• Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells.

  2015cited by this paper
• Targeting Cancer Cells Using LNA-Modified Aptamer-siRNA Chimeras

  2015cited by this paper
• EpCAM Aptamer-siRNA Chimera Targets and Regress Epithelial Cancer

  2015cited by this paper
• Nucleic acid-based aptamers: applications, development and clinical trials.

  2015cited by this paper
• Chimeric nucleolin aptamer with survivin DNAzyme for cancer cell targeted delivery.

  2015cited by this paper
• A straightforward modification in the thrombin binding aptamer improving the stability, affinity to thrombin and nuclease resistance.

  2014cited by this paper
• Integrated Analysis of Dysregulated miRNA-gene Expression in HMGA2-silenced Retinoblastoma Cells

  2014cited by this paper
• The genomic landscape of retinoblastoma: a review

  2014cited by this paper
• Hmga2 regulates self-renewal of retinal progenitors

  2014cited by this paper
• Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway

  2014cited by this paper
• HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis

  2013cited by this paper
• Histopathology of retinoblastoma: Does standardization make a difference in reporting?

  2013cited by this paper
• HMGA2 is a driver of tumor metastasis.

  2013cited by this paper
• Oncogenic microRNA 17-92 cluster is regulated by epithelial cell adhesion molecule and could be a potential therapeutic target in retinoblastoma

  2012cited by this paper
• Molecular deregulation induced by silencing of the high mobility group protein A2 gene in retinoblastoma cells

  2012cited by this paper
• HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.

  2012cited by this paper
• Retinoblastoma

  2012cited by this paper
• Molecular Pathogenesis of Hepatocellular Carcinoma: Altering Transforming Growth Factor-β Signaling in Hepatocarcinogenesis

  2011cited by this paper
• Expression of High Mobility Group A2 Protein in Retinoblastoma and its Association With Clinicopathologic Features

  2009cited by this paper
• The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.

  2008cited by this paper
• HMGA2 and Smads Co-regulate SNAIL1 Expression during Induction of Epithelial-to-Mesenchymal Transition*

  2008cited by this paper
• A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells

  2005cited by this paper
• Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancer

  2004cited by this paper
• Derepression of HMGA2 Gene Expression in Retinoblastoma Is Associated with Cell Proliferation

  2003cited by this paper
• Molecular biology of HMGA proteins: hubs of nuclear function.

  2001cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Apoptosis cascade progresses during turnover of human trophoblast: analysis of villous cytotrophoblast and syncytial fragments in vitro.

  1999cited by this paper
• The expression pattern of the Hmgic gene during development

  1998cited by this paper
• Cytotoxic drugs, programmed cell death, and the immune system: defining new roles in an old play.

  1997cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure.

  1990cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• Nanocarrier based strategies for the treatment and management of eye cancer

  2023cites this paper
• Discovery of Aptamers and the Acceleration of the Development of Targeting Research in Ophthalmology

  2023cites this paper
• Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies.

  2023cites this paper
• Genome maintenance in retinoblastoma: Implications for therapeutic vulnerabilities

  2022cites this paper
• Emerging therapeutic targets for retinoblastoma

  2022cites this paper
• Review: New horizons in retinoblastoma treatment: an updated review article

  2022cites this paper
• Targeting of histone methyltransferase DOT1L plays a dual role in chemosensitization of retinoblastoma cells and enhances the efficacy of chemotherapy

  2021cites this paper
• Targeting the intrinsically disordered architectural High Mobility Group A (HMGA) oncoproteins in breast cancer: learning from the past to design future strategies

  2020cites this paper
• Chromatin regulators in retinoblastoma: Biological roles and therapeutic applications

  2020cites this paper
• [Research advances in the role of aptamers in the diagnosis and targeted therapy of pediatric cancer].

  2018cites this paper
• Over-expression of miR-204 suppresses proliferation and invasion of retinoblastoma cells and its possible mechanism

  2018cites this paper
• Targeting HMGA protein inhibits retinoblastoma cell proliferation

  2018cites this paper
• Aptamer as Therapeutics for Cancer with Focus on Retinoblastoma

  2018cites this paper